Leuprorelin-containing depot products: need to strictly follow instructions for reconstitution and administration to reduce the risk of handling errors that may result in lack of efficacy
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Active substance |
leuprorelin
|
| Procedure number |
EMEA/H/A-31/1486
|
| Regulatory outcome |
Variation
|
| DHPC type |
Referral - Article 31
|
| Referral name |
Leuprorelin-containing depot medicinal products
|